HARVARD BIOSCIENCE INC — Director's Dealing 2017

May 30, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2017-02-06

Reporting Person: Sun Yong (VP - Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-25	Common Stock	A	109130	$0.00	Acquired	217887	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-06	Stock option (right to buy)	$3.25	A	10000	Acquired	2027-02-06	Common Stock, par value $0.01 per share (10000)	Direct

Footnotes

F1: Represents a deferred stock award of 109,130 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021.

F2: Includes (a) a deferred stock award of 109,130 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021; (b) a deferred stock award of 66,755 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (c) a deferred stock award of 8,612 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (d) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 19,332 shares of common stock held by the Reporting Person.

F3: The options vest in four equal installments on February 6, 2018, 2019, 2020 and 2021.